Go back to News
NEWS
GA_P advises Uriach on the minority investment in ICG and the acquisition of French group Laboratories Ineldea
AGómez-Acebo & Pombo has advised Grupo J. Uriach, a Catalan company specialising in the Natural Consumer Healthcare sector, on the entry of the private equity fund ICG in its share capital and on the simultaneous acquisition of the French group Laboratories Ineldea.
With this acquisition, Grupo J. Uriach aims to have a turnover of 450 million euros by 2025, in addition to consolidating its leadership in the Natural Consumer Healthcare business in Europe and strengthening its position in the countries where it already operates, consolidating more powerful local businesses.
The closing of both transactions is subject, among others, to regulatory approvals.
The GA_P team has been led by Daniel Marín, Carolina Posse and Beatriz Dosdá, partner and associates of Corporate, together with Zina Safer, head of the legal department of Grupo J. Uriach. Uriach Group. The transaction has also been advised by Iñigo Igartua, Andrea Díez de Uré and Jesús Urriza, partner and associates of Competition, and Rafael Aguilera and Iñigo Arrieta, partner and associates of Banking.
Read full article
With this acquisition, Grupo J. Uriach aims to have a turnover of 450 million euros by 2025, in addition to consolidating its leadership in the Natural Consumer Healthcare business in Europe and strengthening its position in the countries where it already operates, consolidating more powerful local businesses.
The closing of both transactions is subject, among others, to regulatory approvals.
The GA_P team has been led by Daniel Marín, Carolina Posse and Beatriz Dosdá, partner and associates of Corporate, together with Zina Safer, head of the legal department of Grupo J. Uriach. Uriach Group. The transaction has also been advised by Iñigo Igartua, Andrea Díez de Uré and Jesús Urriza, partner and associates of Competition, and Rafael Aguilera and Iñigo Arrieta, partner and associates of Banking.
Read full article
Category
Deal
Press contact
Sandra Cuesta
Director of Business Development, Marketing and Communications
Sandra Cuesta
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
PUBLICATION
¡NEW!
Automotive and Sustainable Mobility No. 31
Summary of legislative and jurisprudential developments relating to the automotive sector.
PUBLICATION
17 Jul, 2026
Claim assignment and assignment of right to rescind underlying contract
There is no single answer to the question of whether or not the assignee of a claim has the power to rescind the underlying contract when the assigned debtor defaults. As a general rule, such rescission will not be possible for the assignee.
PUBLICATION
16 Jul, 2026
New EU regulation on the screening of foreign investments
Regulation (EU) 2026/1386 establishes a harmonised and mandatory framework for the screening of foreign investments in the Union and replaces the previous Regulation (EU) 2019/452. Among its most notable new features are the obligation for all Member States to have a national screening mechanism with harmonised minimum requirements; the inclusion within its scope of investments made by European subsidiaries controlled by third-country investors; the implementation of a two-stage national procedure; and the strengthening of the European cooperation mechanism through a risk-screening system and a more stringent “comply or explain” principle.
Finally, the paper analyses the regulation’s impact on Spain, whose current review mechanism must be adapted in areas such as procedural structure, the review of completed transactions, sectoral expansion, and the penalty regime by 17 January 2028.
PUBLICATION
08 Jul, 2026
Are company directors directly liable for torts attributable to the company?
Debt from liability in tort for third-party damage or loss arises directly against the directors, without prejudice to the fact that, pursuant to Article 38 CC, it also arises simultaneously against the company, to which the non-contractual acts or omissions of its directors are also attributed. This is so true that the liable company (in debt, for example, with the tax authorities as the person liable for the surcharge and the tax penalty owed) may bring an action for contribution against its directors after settling the debt.
PUBLICATION
23 Jun, 2026
Pharma & Healthcare No. 49
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
PUBLICATION
09 Jun, 2026
Partial limitation defences that may be raised in relation to the limitation period within a cartel (Supreme Court Judgment no. 681/2026 of 6 May)
A flawed judgment on a problem that has remained unresolved to date in the truck cartel. The issue is not whether the liability-in-solidum regime applies, but whether co-liable parties can raise personal defences.
PUBLICATION
09 Jun, 2026
The “serious risk” of financial assistance (Supreme Court (First Chamber) Judgment of 5 May 2026)
This paper critically analyses the Supreme Court ruling of 5May 2026, which applies the prohibition on financial assistance to a case involving the sale of treasury shares with deferred payment to the shareholders of the assisting company.
PUBLICATION
04 Jun, 2026
Unanimous shareholders' agreements and dividends in specie
The Supreme Court and the Madrid Provincial Court, following established legal doctrine, have reiterated that a party to a unanimous shareholders’ agreement acts in bad faith if he or she challenges a company resolution passed in compliance with said shareholders’ agreement. In this case, the shareholders’ agreement provided for the possibility of paying dividends in kind, and the contested resolution — which was passed by a majority at the shareholders’ meeting — transferred certain real estate properties to one of the shareholders (with his consent) in payment of the dividend due to him.
PUBLICATION
28 May, 2026
Voluntary takeover bids and squeeze-outs
The Judgment of the Court of Justice of the European Union (Fifth Chamber) of 13 May 2026 (Korfin and Sempiola v Slovnaft, Case C-225/25) clarifies the concept of a takeover bid for the purposes of Article 2 of the 2004 Takeover Bids Directive, such that an offer made to the holders of securities of a company with a view to acquiring all or some of those securities does not fall within the concept of a takeover bid where it is made by an offeror who already controls the offeree company. Consequently, based on that court’s interpretation of the Directive’s provisions, there is no right of squeeze-out in such voluntary takeover bids.